ASO Author Reflections: Pathologic Complete Response of Extended CROSS Criteria Patients with Esophageal Cancer.
作者信息
Wang H H, Plukker J Th M, Hospers G A P
机构信息
Department of Surgical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
出版信息
Ann Surg Oncol. 2021 Jul;28(7):3961-3962. doi: 10.1245/s10434-020-09438-x. Epub 2020 Dec 7.
Abstract
摘要
相似文献
1
ASO Author Reflections: Pathologic Complete Response of Extended CROSS Criteria Patients with Esophageal Cancer.
Ann Surg Oncol. 2021 Jul;28(7):3961-3962. doi: 10.1245/s10434-020-09438-x. Epub 2020 Dec 7.
2
ASO Author Reflections: The Impact of Preoperative Chemotherapy on Survival After Esophagectomy in Elderly Patients with Esophageal Cancer.
Ann Surg Oncol. 2021 Mar;28(3):1796-1797. doi: 10.1245/s10434-020-09078-1. Epub 2020 Aug 28.
3
ASO Author Reflections: Recurrence After Pathological Complete Response in Esophageal Cancer: Analysis of Risk Factors for this Unexpected Event.
Ann Surg Oncol. 2021 Jun;28(6):3044-3045. doi: 10.1245/s10434-020-09352-2. Epub 2020 Nov 11.
4
ASO Author Reflections: The Impact of Early Skeletal Muscle Loss Within 1 Week After Esophagectomy on Long-term Prognosis in Patients with Esophageal Cancer.
Ann Surg Oncol. 2021 Oct;28(11):6388-6389. doi: 10.1245/s10434-021-09670-z. Epub 2021 Feb 26.
5
ASO Author Reflections: The Impact of Minimally Invasive McKeown on Survival in Patients with Resectable Esophageal Cancer.
Ann Surg Oncol. 2021 Oct;28(11):6337-6338. doi: 10.1245/s10434-021-10106-x. Epub 2021 May 3.
6
ASO Author Reflections: Actual Sarcopenia in Esophageal Cancer Patients.
Ann Surg Oncol. 2022 Jun;29(6):3682. doi: 10.1245/s10434-022-11339-0. Epub 2022 Jan 22.
7
ASO Author Reflections: Achieving Adequate Lymphadenectomy in Esophageal Cancer Resection.
Ann Surg Oncol. 2020 Oct;27(11):4457-4458. doi: 10.1245/s10434-020-08588-2. Epub 2020 May 14.
8
ASO Author Reflections: Establishment of an Ideal Criterion for Evaluating the Therapeutic Effect on Esophageal Cancer.
Ann Surg Oncol. 2021 Dec;28(13):8483-8484. doi: 10.1245/s10434-021-10330-5. Epub 2021 Jul 27.
9
ASO Author Reflections: Opting for a Cost-Effective Treatment Allocation in Patients with Esophageal Cancer.
Ann Surg Oncol. 2022 Jun;29(6):3654-3655. doi: 10.1245/s10434-021-11230-4. Epub 2022 Jan 13.
10
ASO Author Reflections: Cervicothoracoscopic Esophagectomy for Esophageal Cancer.
Ann Surg Oncol. 2020 May;27(5):1531-1532. doi: 10.1245/s10434-020-08283-2. Epub 2020 Mar 2.
引用本文的文献
1
The long-term outcomes of laparoscopic versus open pancreatoduodenectomy for ampullary carcinoma showed similar survival: a case-matched comparative study.
Surg Endosc. 2022 Jul;36(7):4732-4740. doi: 10.1007/s00464-021-08813-3. Epub 2021 Nov 1.
2
The outcome of laparoscopic pancreatoduodenectomy is improved with patient selection and the learning curve.
Surg Endosc. 2022 Mar;36(3):2070-2080. doi: 10.1007/s00464-021-08493-z. Epub 2021 Apr 21.
3
ASO Author Reflections: Preoperative Assessment of Remnant Liver Function.
Ann Surg Oncol. 2021 Jul;28(7):3683-3684. doi: 10.1245/s10434-020-09364-y. Epub 2020 Nov 17.
本文引用的文献
1
A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results.
Trials. 2015 Nov 3;16:495. doi: 10.1186/s13063-015-1023-4.
2
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial.
Lancet Oncol. 2015 Sep;16(9):1090-1098. doi: 10.1016/S1470-2045(15)00040-6. Epub 2015 Aug 5.
3
Preoperative chemoradiotherapy for esophageal or junctional cancer.
N Engl J Med. 2012 May 31;366(22):2074-84. doi: 10.1056/NEJMoa1112088.
Zotero 插件